PTPN9 regulates HER3 phosphorylation during trastuzumab treatment and loss of PTPN9 is a potential biomarker for trastuzumab resistance in HER2 positive breast cancer.
作者信息
Azad Abul, Arshad Maryam, Generali Daniele, Feldinger Katharina, Gijsen Merel, Strina Carla, Cappelletti Mariarosa, Andreis Daniele, Leek Russell, Haider Syed, Kellokumpu-Lehtinen Pirkko-Liisa, Roxanis Ioannis, Harris Adrian Llewellyn, Shaaban Abeer Mahmoud, Joensuu Heikki, Kong Anthony
机构信息
Department of Oncology, The Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Institute of Genomic and Cancer Sciences, Vincent Drive, University of Birmingham, Birmingham, UK.
出版信息
Cancer Commun (Lond). 2025 Jan;45(1):68-73. doi: 10.1002/cac2.12632. Epub 2024 Nov 24.
Abstract
摘要
Zotero 插件